Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients

Cytotherapy. 1999;1(5):401-7. doi: 10.1080/0032472031000141284.

Abstract

Background: Mismatched family donor and unrelated donor BM transplants are associated with a high risk of acute GvHD. White T-cell depletion is the best method to reduce risk of acute GvHD, there was a reluctance to use T-cell depletion in the mismatched setting because of increased risk of rejection and relapse. Partial T-cell depletion, by the panning of CDS and CD8 positive T cells may reduce complications related to GvHD without compromising outcomes.

Method: In a long-term follow-up of a Phase II study of partial T-cell depletion by panning for BM transplant, 32 recipients received transplants from a single-Ag (HLA A, B, or DR) mismatched family donor; or an HLA serologically-matched unrelated donor. Patients were studied for engraftment, GHD, relapse and survival.

Results: 30 (94%) of the patients marrow engrafted. The cumulative risk of Grade 2-4 acute GvHD was 62 - 9%; of Grade 3-4 GvHD, 11 - 6%. The 4-year cumulative risk of relapse was 18 - 8% and actuarial survival was 44 - 9%.

Discussion: Partial T-cell depletion had a low rate of severe acute GvHD without compromising engrafment or relapse risk.

Publication types

  • Clinical Trial, Phase II

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Cells / cytology
  • Bone Marrow Transplantation / methods*
  • CD5 Antigens / biosynthesis*
  • CD8-Positive T-Lymphocytes / metabolism*
  • Child
  • Female
  • Follow-Up Studies
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / prevention & control
  • Histocompatibility
  • Humans
  • Leukemia / therapy
  • Lymphoma / therapy
  • Male
  • Recurrence
  • Treatment Outcome

Substances

  • CD5 Antigens